Lori Rice

481 total citations
20 papers, 382 citations indexed

About

Lori Rice is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lori Rice has authored 20 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Lori Rice's work include Cancer, Hypoxia, and Metabolism (3 papers), Phytoestrogen effects and research (3 papers) and Fibroblast Growth Factor Research (2 papers). Lori Rice is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Phytoestrogen effects and research (3 papers) and Fibroblast Growth Factor Research (2 papers). Lori Rice collaborates with scholars based in United States, Denmark and China. Lori Rice's co-authors include Dietmar W. Siemann, Christine Pampo, Von G. Samedi, Henry V. Baker, Kathleen T. Shiverick, Dhivya R. Sudhan, Jaime Furman, Yuehua Cui, Nancy J. Szabo and Kulam Najmudeen Magdoom and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lori Rice

19 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Rice United States 13 159 88 76 74 60 20 382
Jie Meng China 12 253 1.6× 40 0.5× 135 1.8× 108 1.5× 34 0.6× 27 472
Bastian Czogalla Germany 15 237 1.5× 74 0.8× 103 1.4× 176 2.4× 54 0.9× 64 620
Rudy Gadet France 12 294 1.8× 45 0.5× 54 0.7× 60 0.8× 45 0.8× 16 473
Guohua Liu China 10 267 1.7× 59 0.7× 132 1.7× 55 0.7× 24 0.4× 18 447
Olivia Beseme France 15 265 1.7× 85 1.0× 69 0.9× 66 0.9× 36 0.6× 32 537
Runxia Gu China 10 132 0.8× 36 0.4× 48 0.6× 111 1.5× 33 0.6× 41 412
Xinhui Wang China 12 330 2.1× 50 0.6× 95 1.3× 150 2.0× 51 0.8× 30 516
Prudence A. Cowled Australia 12 193 1.2× 51 0.6× 47 0.6× 60 0.8× 105 1.8× 16 433
Lin Xiao China 14 248 1.6× 28 0.3× 134 1.8× 107 1.4× 102 1.7× 57 513

Countries citing papers authored by Lori Rice

Since Specialization
Citations

This map shows the geographic impact of Lori Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Rice more than expected).

Fields of papers citing papers by Lori Rice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Rice. The network helps show where Lori Rice may publish in the future.

Co-authorship network of co-authors of Lori Rice

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Rice. A scholar is included among the top collaborators of Lori Rice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Rice. Lori Rice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okunieff, Paul, Steven G Swarts, Bruce M. Fenton, et al.. (2024). Radiation Biological Toximetry Using Circulating Cell-Free DNA (cfDNA) for Rapid Radiation/Nuclear Triage. Radiation Research. 202(1). 70–79. 3 indexed citations
2.
Narla, Sridhar, Lori Rice, David A. Ostrov, et al.. (2022). FGF7 peptide (FGF7p) mimetic mitigates bladder urothelial injury from cyclophosphamide. Physiological Reports. 10(7). e15241–e15241. 3 indexed citations
3.
Narla, Sridhar, et al.. (2022). Durability of and role of AKT in FGF7p urothelial protection against cyclophosphamide. Physiological Reports. 10(12). e15358–e15358. 1 indexed citations
4.
5.
Lønbro, Simon, Jennifer Wiggins, Thomas R. Wittenborn, et al.. (2019). Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill running. PLoS ONE. 14(5). e0215584–e0215584. 29 indexed citations
6.
Bohórquez, Ana C., Mythreyi Unni, Andreina Chiu‐Lam, et al.. (2018). Stability and Mobility of Magnetic Nanoparticles in Biological Environments Determined from Dynamic Magnetic Susceptibility Measurements. Bioconjugate Chemistry. 29(8). 2793–2805. 16 indexed citations
7.
Wiggins, Jennifer, et al.. (2016). Abstract 732: The impact of aerobic exercise on the tumor microenvironment. Cancer Research. 76(14_Supplement). 732–732.
8.
Sudhan, Dhivya R., Christine Pampo, Lori Rice, & Dietmar W. Siemann. (2016). Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model. International Journal of Cancer. 138(11). 2665–2677. 38 indexed citations
9.
Lee, Jennifer A., Jennifer Wiggins, Lori Rice, & Dietmar W. Siemann. (2015). Abstract 5211: In vivo fluorescence and spectral microscopy of the effects of aerobic exercise on tumor oxygenation and perfusion in breast cancer. Cancer Research. 75(15_Supplement). 5211–5211. 2 indexed citations
10.
Magdoom, Kulam Najmudeen, et al.. (2014). MRI-Based Computational Model of Heterogeneous Tracer Transport following Local Infusion into a Mouse Hind Limb Tumor. PLoS ONE. 9(3). e89594–e89594. 25 indexed citations
11.
Jia, Di, Sean M. Hasso, Joanne Chan, et al.. (2012). Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo. Blood. 121(4). 707–715. 35 indexed citations
12.
Rice, Lori, et al.. (2011). Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells. Clinical & Experimental Metastasis. 29(2). 133–142. 33 indexed citations
13.
Rice, Lori, et al.. (2010). Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503. Microvascular Research. 81(1). 44–51. 17 indexed citations
14.
Rice, Lori, et al.. (2010). Impact of the Src inhibitor saracatinib on the metastatic phenotype of a fibrosarcoma (KHT) tumor model.. PubMed. 30(11). 4405–13. 18 indexed citations
15.
DeBoer, Rebecca, Sean Grimm, James R. Chandler, et al.. (2008). A phase II trial of PTK-787 (PTK/ZK) in recurrent or progressive meningiomas. Journal of Clinical Oncology. 26(15_suppl). 2060–2060. 8 indexed citations
16.
Rice, Lori, Yuehua Cui, Von G. Samedi, et al.. (2007). Soy Isoflavones Exert Differential Effects on Androgen Responsive Genes in LNCaP Human Prostate Cancer Cells. Journal of Nutrition. 137(4). 964–972. 17 indexed citations
17.
Rice, Lori, Yuehua Cui, Von G. Samedi, et al.. (2006). Soy Isoflavones Alter Expression of Genes Associated with Cancer Progression, Including Interleukin-8, in Androgen-Independent PC-3 Human Prostate Cancer Cells. Journal of Nutrition. 136(1). 75–82. 57 indexed citations
18.
Rice, Lori, et al.. (2002). Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts*. The Prostate. 52(3). 201–212. 51 indexed citations
19.
Furman, Jaime, William M. Murphy, Lori Rice, Peter A. Drew, & Perinchery Narayan. (1998). Prostatectomy Tissue for Research: Balancing Patient Care and Discovery. American Journal of Clinical Pathology. 110(1). 4–9. 12 indexed citations
20.
Rice, Lori, et al.. (1992). Use of oral tolerance tests to investigate disaccharide digestion in neonatal foals2. Journal of Animal Science. 70(4). 1175–1181. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026